Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Phase I SBIR grant supports preclinical work for ALS-886 for stroke

Feb. 10, 2006

Pivotal phase II/III MS trial of MBP-8298 recommended to continue

Feb. 10, 2006

New Abilify options now available

Feb. 9, 2006

MC4 antagonist/serotonin transport inhibitor for stress-related anxiety and depression

Feb. 9, 2006

PBT-2 completes phase I program

Feb. 9, 2006

TRO-19622 completes phase I trials

Feb. 9, 2006

IND cleared for phase I study of Tramadol ER

Feb. 9, 2006

CHMP recommends approval of Exelon for Parkinson's disease dementia

Feb. 8, 2006

Bicifadine studied in new phase II trial for diabetic peripheral neuropathy

Feb. 8, 2006

Research collaboration to evaluate nasal delivery for Alzheimer's disease

Feb. 8, 2006

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...